...
首页> 外文期刊>Acute and critical care. >Veno-arterial extracorporeal membrane oxygenation may be useful in critically ill COVID-19 patients with suspected cardiac injury
【24h】

Veno-arterial extracorporeal membrane oxygenation may be useful in critically ill COVID-19 patients with suspected cardiac injury

机译:静脉动脉体外膜氧合可用于严重的Covid-19疑似心损伤的患者

获取原文

摘要

Recent studies reported that 12%–19.7% of patients with coronavirus disease-19 (COVID-19)exhibit cardiac injuries manifesting as an ejection fraction decline and troponin I elevation[1,2]. Cardiac injury is associated with higher mortality, the need for ICU care, and severeCOVID-19 [3]. Recently, a 63-year-old man presented to Seoul Metropolitan GovernmentSeoulNational University Boramae Medical Center with severe respiratory manifestationsand fulminant myocarditis with an enlarged left ventricle and depressed left ventricular function(ejection fraction 32%). He was placed on extracorporeal membrane oxygenation (ECMO).After treatment with intravenous immunoglobulin, steroids, and antiviral therapy, heart functionrecovered within 2 weeks .
机译:最近的研究报告称,12%-19.7%的冠状病毒病-19患者(Covid-19)表现出表现为射血分数下降和肌钙蛋白I升降[1,2]的心脏损伤[1,2]。心脏损伤与较高的死亡率有关,对ICU护理的需求和SevereCovid-19 [3]。最近,一名63岁的男子向首尔大都会政府大学Boramae Medical Centr,具有严重的呼吸道表现和暴发性心肌炎,左心室扩大和抑郁的左心室功能(喷射分数32%)。他被置于体外膜氧合(ECMO)。用静脉内免疫球蛋白,类固醇和抗病毒治疗治疗,心脏在2周内恢复的心脏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号